FDA Approved: NERLYNX — Original Application (Puma Biotechnology, Inc.)

View source ↗

Summary

FDA approved Nerlynx (neratinib) as the original application for extended adjuvant therapy in adult patients with early-stage HER2-positive breast cancer who ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nerlynx (neratinib)

Snippet

ORIG AP for NERLYNX (NERATINIB)